5 March 20201 min read

Medicspot publishes State of Pharmacy report with NPA

Lucas Wickens

Head of Brand & Comms at Medicspot

Medicspot has published its first annual State of Pharmacy report, diving into the pressing issues facing pharmacy, including the new government contract, funding cuts and Brexit.

With the support of the National Pharmacy Association (NPA), we’ve surveyed over a hundred pharmacists across the UK, collecting 2,750+ data points to build an accurate snapshot of pharmacy in 2020.

We have enlisted key pharmacy stakeholders to share their expertise and insights on the future of pharmacy as we begin a new decade, including Mark Lyonette, CEO of the NPA; Phil Galt, NPA Board Member for Scotland and MD of the Lindsay & Gilmour group; Sanjay Ganvir, Director at the Green Light group; and Saam Ali, CEO of Pharmacy Mentor.

The Medicspot State of Pharmacy report was featured in pharmaceutical publications including Pharmacy MagazinePf MagazineEuropean Pharmaceutical ReviewPharmacy Business and PharmaTimes.

One of the key takeaways from our State of Pharmacy report was that pharmacists are looking towards private services as concerns over the government’s new pharmacy contract grow.

As many as eight in ten pharmacists (81%) in England believe their revenue will decrease as a result of the new government contract, and 85% say they hope to dispense more private prescriptions in 2020.

Mark Lyonette, CEO of the NPA, says: “Setting up private pharmacy services can be both professionally and financially rewarding for pharmacists and can also increase the footfall to the pharmacy.”

Sanjay Ganvir, Director at Green Light Pharmacy group believes pharmacy should be the first port of call for the public and suggests private services could be a solution:

“Pharmacists should strengthen links with prescribers, in particular utilising innovative technology such as Medicspot to allow GP consultations in the pharmacy via video link, while also developing their own independent prescribing skills and embracing PGDs”, explains Ganvir.


Browse other Medicspot content